Informing radiotherapy decisions in stage I/IIa Hodgkin lymphoma: modeling life expectancy using radiation dosimetry

In recent randomized trials, omitting consolidative radiotherapy (RT) in early-stage Hodgkin lymphoma (ESHL) increased relapses. However, decades of follow-up are required to observe whether lower initial disease control is compensated by reduced risk of late effects. Extrapolation beyond trial foll...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, David A., Candio, Paolo, Shakir, Rebecca, Ntentas, Georgios, Ramroth, Johanna, Gray, Alastair M., Cutter, David J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Lymphoid Neoplasia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945315/
https://www.ncbi.nlm.nih.gov/pubmed/34872107
http://dx.doi.org/10.1182/bloodadvances.2021006254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945315/
https://www.ncbi.nlm.nih.gov/pubmed/34872107
http://dx.doi.org/10.1182/bloodadvances.2021006254

Ejemplares similares